Clinical Trials
102 trialsEndoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)
IHU Strasbourg
A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
BESTa
Karolinska Institutet
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
Inova Health Care Services
Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?
University of Edinburgh
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
City of Hope Medical Center
EMPIRE
Institut Bergonié
TCR1020-CD8 T Cells in KRAS-mutated Cancers
University of Pennsylvania
A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer
ProgenaBiome
Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
Memorial Sloan Kettering Cancer Center
UNTIRE: Cancer-related Fatigue With Digital Treatment
Dana-Farber Cancer Institute
Molecular Effects of Aspirin & Metformin on Colonic Epithelium
University of Edinburgh
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
University of Colorado, Denver
Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer
City of Hope Medical Center
Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy
Indiana University
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Wake Forest University Health Sciences
Pedaling at a Low-Moderate Intensity During Chemotherapy Administration
Rush University Medical Center
Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)
Roswell Park Cancer Institute
Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study
Academic and Community Cancer Research United
Intraperitoneal LSTA1 in CRS-HIPEC
University of California, San Diego
Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
Sun Yat-sen University
Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
M.D. Anderson Cancer Center
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
Case Comprehensive Cancer Center
#CuttingCRC: Barbershop-Based Trial & Colorectal Cancer
Medical College of Wisconsin
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
XHZL
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ColErn
Norwegian University of Science and Technology
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer
M.D. Anderson Cancer Center
Abscopal Effect for Metastatic Colorectal Cancer
Zhejiang Provincial People's Hospital
Bohème
Ospedale Policlinico San Martino
Anesthesia, TIVA, Balanced Anesthesia, NK Cell
Gangnam Severance Hospital
REFIT-MSS
Translational Research in Oncology
Technology-Based Cancer Screening Intervention
Medical University of South Carolina
The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
The University of Texas Medical Branch, Galveston
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
King Hussein Cancer Center
PREDICT
Kaiser Permanente
MATILDA
Gustave Roussy, Cancer Campus, Grand Paris
Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer
Translational Genomics Research Institute
Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Federation Francophone de Cancerologie Digestive
Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University
A Mobile Aplication for the Promotion of Healthy Lifestyle Habits in Patients With Colorectal Cancer
Universidad de Granada
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer
Roswell Park Cancer Institute
Anti-PD-1 +/- RT for MSI-H Solid Tumors
University of Colorado, Denver
OMICC
Massachusetts General Hospital
Evaluating the Cologuard Test for Use in Lynch Syndrome
Geisinger Clinic
IMMUNOX
Herlev Hospital
mSILSC
Ruijin Hospital
Visbiome Effect on Colorectal Anastomosis and Local Recurrence
University of Louisville
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
University of Southern California